Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $279.00B · View financials
Decision snapshot: AVTX stock price vs TM: inconclusive — current versus $0.00 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TM's multiple
Implied fair value · at AVTX's multiple
Needs AVTX P/S.
Live quote
As of 2025-12-31
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AVTX FY 2025 (ended Dec 31, 2025) · TM FY 2025 (ended Mar 31, 2025). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 78% equity / 22% debt · EV / Revenue 0.72x · EV / EBITDA 2117.91x
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
AVALO THERAPEUTICS, INC. · implied price per share
Bear
$1.24
Base
$1.45
Bull
$1.67
TOYOTA MOTOR CORP/ · implied price per share
Bear
-$9.66K
Base
-$11.37K
Bull
-$13.07K
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.24x
0.57x
Net debt / EBITDA
Leverage against operating earnings
1.03x
-545.88x
Cash and equivalents
Liquid reserves on the balance sheet
$98.34M
$9.00T
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CytomX Therapeutics, Inc.
AVTX vs CTMX
IDEAYA Biosciences, Inc.
AVTX vs IDYA
Ocugen, Inc.
AVTX vs OCGN
CLOVER HEALTH INVESTMENTS, CORP. /DE
AVTX vs CLOV
Citius Pharmaceuticals, Inc.
AVTX vs CTXR
FORD MOTOR CO
AVTX vs F
General Motors Co
AVTX vs GM
Tesla, Inc.
AVTX vs TSLA
HONDA MOTOR CO LTD
AVTX vs HMC
$20.26M
$78.02B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
